Table 2.
Univariate and multivariate analyses for 15-year distant metastasis-free survival
Sagara Hospital + AMC | ||||||
---|---|---|---|---|---|---|
Univariate | Multivariate | |||||
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
BCT risk (low vs. high) | 7.20 | 3.80–13.65 | < 0.001 | 4.59 | 2.13–9.88 | < 0.001 |
Tumor size (≤ 2 cm vs. > 2 cm) | 4.33 | 2.28–8.22 | < 0.001 | 1.72 | 0.81–3.67 | 0.161 |
Positive nodes (0–3) | 1.79 | 1.19–2.70 | 0.005 | 1.05 | 0.63–1.77 | 0.839 |
Histologic grade (1 vs. 2/3) | 3.12 | 1.11–8.80 | 0.031 | 2.18 | 0.76–6.26 | 0.146 |
Age (≤ 50 vs. > 50 years) | 2.05 | 1.03–4.06 | 0.041 | 1.38 | 0.67–2.86 | 0.383 |
Sagara Hospital (Japan) | ||||||
---|---|---|---|---|---|---|
Univariate | Multivariate | |||||
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
BCT risk (low vs. high) | 7.18 | 2.88–17.89 | < 0.001 | 3.92 | 1.38–11.14 | 0.010 |
Tumor size (≤ 2 cm vs. > 2 cm) | 3.73 | 1.50–9.31 | 0.005 | 1.62 | 0.59–4.50 | 0.353 |
Positive nodes (0–3) | 2.55 | 1.61–4.04 | < 0.001 | 2.06 | 1.18–3.58 | 0.011 |
Histologic grade (1 vs. 2/3) | 6.82 | 1.58–29.51 | 0.010 | 6.26 | 1.43–27.45 | 0.015 |
Age (≤ 50 vs. > 50 years) | 0.83 | 0.33–2.07 | 0.687 | – | – | – |
AMC (Korea) | ||||||
---|---|---|---|---|---|---|
Univariate | Multivariate | |||||
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
BCT risk (low vs. high) | 7.26 | 2.94–17.90 | < 0.001 | 4.22 | 1.46–12.19 | 0.008 |
Tumor size (≤ 2 cm vs. > 2 cm) | 4.95 | 2.01–12.20 | < 0.001 | 1.64 | 0.56–4.83 | 0.371 |
Positive nodes (0–3) | 0.95 | 0.33–2.75 | 0.929 | – | – | – |
Histologic grade (1 vs. 2/3) | 1.70 | 0.39–7.37 | 0.477 | – | – | – |
Age (≤ 50 vs. > 50 years) | 4.58 | 1.52–13.81 | 0.007 | 2.60 | 0.79–8.56 | 0.115 |
AMC, Asan Medical Center; CI, confidence interval
P values < 0.05 are marked in bold